🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the safety, tolerability and effi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-01-15
Trial ID
NCT05048342
Treatments Being Tested
The purpose of this Phase 3b study is to assess the efficacy, safety and to...
Status
Recruiting
Location
Perseverance Research Center
Start Date
2025-06-23
Trial ID
NCT06846281
Treatments Being Tested
Prospective, non-interventional study in patients with CSU where the treatm...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2026-08-04
Trial ID
NCT07642557
A study to evaluate the safety, efficacy and tolerability of remibrutinib a...
Status
Completed
Location
Allervie Clinical Research
Start Date
2022-10-12
Trial ID
NCT05432388
Prospective, multi-country, non-interventional study in patients with CSU w...
Status
Recruiting
Location
Cleaver Dermatology
Start Date
2026-02-02
Trial ID
NCT07358364
The purpose of this study is to establish the efficacy, safety, and tolerab...
Status
Active Not Recruiting
Location
Total Skin and Beauty Dermatology Center PC
Start Date
2025-03-20
Trial ID
NCT06840392
Treatments Being Tested
Prospective, non-interventional study in patients with CSU where the treatm...
Status
Recruiting
Location
Cleaver Dermatology
Start Date
2026-02-02
Trial ID
NCT07358780
This is a US, multi-center, randomized, double-blind, double-dummy, Phase 3...
Status
Recruiting
Location
Allervie Clinical Research
Start Date
2025-07-11
Trial ID
NCT06868212
Treatments Being Tested
This is a 6-part first-in-human study in up to approximately 184 participan...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-08-18
Trial ID
NCT03918980
Multi-center, open-label roll-over post-trial access protocol to provide re...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2026-04-16
Trial ID
NCT07456891
Treatments Being Tested